Jaehong Kim, Shanshan Wang, Slaven Sikirica, & Jason Shafrin. (2024). Cost-effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failure. Becaris Publishing Limited.
Chicago Style (17th ed.) CitationJaehong Kim, Shanshan Wang, Slaven Sikirica, and Jason Shafrin. Cost-effectiveness of Sotagliflozin for the Treatment of Patients with Diabetes and Recent Worsening Heart Failure. Becaris Publishing Limited, 2024.
MLA (9th ed.) CitationJaehong Kim, et al. Cost-effectiveness of Sotagliflozin for the Treatment of Patients with Diabetes and Recent Worsening Heart Failure. Becaris Publishing Limited, 2024.
Warning: These citations may not always be 100% accurate.